Evidence map›Paper›PMID 39881834›Full record

ArticleSovremennye tekhnologii v meditsine2024

Evaluation of Skin Recovery after Fractional CO

M A Sirotkina, A L Potapov, M M Loginova, A E Bychkova, A A Moiseev, M V Kochuyeva, A Yu Bogomolova, E B Kiseleva, A V Asaturova, A V Maslennikova and 3 more

Abstract read
In one paragraph

Article in Sovremennye tekhnologii v meditsine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

M A SirotkinaPhD, Director, Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
A L PotapovLaboratory Assistant, Laboratory of Optical Coherence Tomography, Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
M M LoginovaPhD, Junior Researcher, Laboratory of Optical Coherence Tomography, Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
A E BychkovaObstetrician-Gynecologist, Esthetic Gynecology and Rehabilitation Unit; National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov of the Russian Ministry of Health, 4 Academician Oparin St., Moscow, 117997, Russia.
A A MoiseevPhD, Senior Researcher, Laboratory of High-Sensitivity Optical Measurements; Federal Research Center Institute of Applied Physics of the Russian Academy of Sciences, 46 Ulyanova St., Nizhny Novgorod, 603950, Russia.
M V KochuyevaOncologist, Head of the Center for Outpatient Oncological Aid, MEDSI Clinic in Otradnoye; MEDSI Group of Companies, 3a Gruzinsky Alley, Moscow, 123056, Russia.
A Yu BogomolovaLaboratory Assistant, Laboratory of Regenerative Medicine, Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
E B KiselevaPhD, Senior Researcher, Laboratory of Optic Coherence Tomography, Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
A V AsaturovaMD, DSc, Head of the 1 Department of Pathology; National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov of the Russian Ministry of Health, 4 Academician Oparin St., Moscow, 117997, Russia.
A V MaslennikovaMD, DSc, Professor, Head of the Department of Oncology, Radiotherapy and Diagnostic Radiology; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia; Radiotherapist; Nizhny Novgorod Regional Oncologic Dispensary, 11/1 Delovaya St., Nizhny Novgorod, 603093, Russia.
S G Radenska-LopovokMD, DSc, Professor, Institute of Clinical Morphology and Digital Pathology; I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Trubetskaya St., Moscow, 119991, Russia.
L A ApolikhinaMD, DSc, Professor, Head of the Esthetic Gynecology and Rehabilitation Unit; National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov of the Russian Ministry of Health, 4 Academician Oparin St., Moscow, 117997, Russia; Professor, Department of Obstetrics, Gynecology, Perinatology, and Reproductology; I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Trubetskaya St., Moscow, 119991, Russia.
N D GladkovaMD, DSc, Professor, Head of the Laboratory of Optical Coherence Tomography Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materials and Methods: The study included 3 clinical cases of vulvar lichen sclerosus (VLS) (histologically classified as early, early with dermal edema, late) and 2 control cases without vulvar pathology. Patients with VLS underwent 3 procedures of fractional CO Results: Analyzing the case series of vulvar skin recovery 1 month after fractional CO Conclusion: MM OCT can be proposed as a promising non-invasive method for monitoring skin recovery after fractional CO

Indexed as

Lasers, GasTomography, Optical CoherenceAdultFemaleHumansMiddle AgedSkinTreatment OutcomeVulvar Lichen Sclerosusangiographyfractional CO2 laserlymphangiographyMM OCTmultimodal optical coherence tomographyOCT signal attenuation coefficientvulvar lichen sclerosis

Identifiers

PMID39881834
PMCPMC11773141

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.